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Loss of mRNA surveillance 
pathways results in widespread 
protein aggregation
Nur Hidayah Jamar1,2, Paraskevi Kritsiligkou  1 & Chris M. Grant  1
Eukaryotic cells contain translation-associated mRNA surveillance pathways which prevent the 
production of potentially toxic proteins from aberrant mRNA translation events. We found that loss 
of mRNA surveillance pathways in mutants deficient in nonsense-mediated decay (NMD), no-go 
decay (NGD) and nonstop decay (NSD) results in increased protein aggregation. We have isolated 
and identified the proteins that aggregate and our bioinformatic analyses indicates that increased 
aggregation of aggregation-prone proteins is a general occurrence in mRNA surveillance mutants, 
rather than being attributable to specific pathways. The proteins that aggregate in mRNA surveillance 
mutants tend to be more highly expressed, more abundant and more stable proteins compared with 
the wider proteome. There is also a strong correlation with the proteins that aggregate in response to 
nascent protein misfolding and an enrichment for proteins that are substrates of ribosome-associated 
Hsp70 chaperones, consistent with susceptibility for aggregation primarily occurring during translation/
folding. We also identified a significant overlap between the aggregated proteins in mRNA surveillance 
mutants and ageing yeast cells suggesting that translation-dependent protein aggregation may be a 
feature of the loss of proteostasis that occurs in aged cell populations.
Protein aggregation is the abnormal association of misfolded proteins into aggregated, insoluble protein struc-
tures1. It is often classified into two general categories: amyloid and amorphous. The amyloid state is a highly 
structured, insoluble, fibrillar deposit, usually consisting of many repeats of the same protein2. It is central to the 
pathology of many neurodegenerative diseases including Alzheimer’s, Parkinson’s and Huntington’s. Amorphous 
protein aggregation is the unordered aggregation of proteins, where proteins aggregate without forming a specific 
higher order structure. The aggregation of amyloid proteins has been more extensively studied since it is impli-
cated in the pathogenesis of several neurological diseases, whereas, less is known regarding amorphous aggrega-
tion. It is not clearly established whether aggregation of amorphous proteins is mechanistically and functionally 
any different to amyloid proteins in terms of impact to the physiological state of the cell. Additionally, whether the 
proteins in disease settings are in fact amyloid or amorphous has not been well characterised. Proteins may also 
form amyloid progressively from initial disordered aggregates3.
Protein aggregation occurs following protein misfolding, which arises as a consequence of translational errors 
during stress and ageing conditions, as well as a consequence of mutations or lack of oligomeric assembly part-
ners4,5. Such conditions disrupt the native folding of proteins, exposing hydrophobic regions leading to the for-
mation of high molecular weight aggregates. Newly synthesized proteins are particularly vulnerable to misfolding 
and aggregation which is potentially toxic to cells6–8. A wide-range of proteins are prone to aggregation during 
normal unstressed conditions, with higher protein abundances and higher translation rates suggested as being 
the main determinants9–11. Aggregated proteins are also often substrates of ribosome-associated Hsp70 chap-
erones indicating that they are likely to be susceptible to aggregation during translation and folding9. Cellular 
stresses appear to reduce the general threshold for protein aggregation resulting in the aggregation of proteins 
which do not possess distinct kinds of physicochemical properties9,10,12,13. Proteins in stress-induced aggregates 
tend to have lower abundances, slower translation rates and increased sizes relative to unstressed protein aggre-
gates. This suggests that protein aggregation is a normal physiological event, but conditions which act to perturb 
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cellular homeostasis, can increase the burden of protein aggregation10. Several aggregation-prone yeast proteins 
have human homologues that are implicated in misfolding diseases, highlighting that similar mechanisms may 
apply in disease and non-disease settings. However, the relevance of widespread protein aggregation in disease 
is unknown.
The process of mRNA decay is recognised as a major contributor to the regulation of gene expression, as well 
as maintaining regulatory responses crucial for cellular homeostasis. mRNA turnover plays critical roles in assess-
ing the accuracy of mRNA biogenesis and in the degradation of aberrant transcripts. These aberrant transcripts 
are recognised and targeted for rapid degradation by mRNA surveillance mechanisms. These surveillance mech-
anisms block the expression of defective mRNAs, which can have deleterious consequences for the cell14–16. There 
are three translation-associated mRNA surveillance pathways that target mRNAs for degradation to prevent the 
production of potentially toxic proteins. Nonsense-mediated decay (NMD) functions to detect premature stop 
codons and prevents the expression of truncated proteins. No-go decay (NGD) recognises transcripts on which 
ribosomes have stalled during translation17. Nonstop decay (NSD) is a quality control system for nonstop mRNAs 
which recognises stalled ribosome at the 3′ end of mRNAs and targets them for rapid degradation18. All of these 
specialised pathways use the same decay enzymes responsible for degrading normal transcripts; however, they 
differ in the mechanism by which they recognise and target defective mRNAs for degradation19.
The importance that mRNA surveillance pathways might have in regulating proteostasis is currently not well 
understood. The aim of this study was to determine whether loss of NSD, NMD or NGD, would have any effects 
on proteostasis by examining protein aggregation in strains defective in mRNA surveillance pathways. We show 
that defects in mRNA quality control systems result in the production of aberrant proteins that tend to misfold 
and form aggregates. The aggregated proteins share common biophysical properties with aggregation-prone pro-
teins, suggesting that mRNA surveillance pathways normally function to suppress defective protein production 
arising from errors in translation.
Results
Disruption of mRNA surveillance pathways causes widespread protein aggregation. To exam-
ine whether protein aggregation occurs following loss of mRNA surveillance pathways, we utilised mutant strains 
disrupted for NGD (dom34, hbs1), NMD (upf1, upf2), NSD (ski7) and the Ski complex (ski8)20. We monitored 
sites of protein aggregation using a fluorescently-tagged Hsp104 chaperone. Hsp104-RFP is predominantly 
observed as diffuse cytoplasmic fluorescence in cells under normal growth conditions, whereas, it accumulates at 
the sites of protein aggregation following protein misfolding21–23. Diffuse cytoplasmic Hsp104-RFP fluorescence 
was detected in the majority of wild-type cells examined and only 3% of cells contained visible puncta marking 
sites of protein aggregation (Fig. 1A and B). In contrast, more puncta were observed in all of the mRNA surveil-
lance mutant strains. The number of Hsp104-RFP puncta detected was elevated approximately three-fold in ski7, 
Figure 1. Strains lacking components of mRNA surveillance pathways have higher levels of protein 
aggregation. (A) Hsp104-RFP was visualized in wild-type and mutant strains disrupted for NGD (dom34, 
hbs1), NMD (upf1, upf2), NSD (ski7) and the Ski complex (ski8). Examples of cells containing visible puncta 
are shown. (B) The percentage of cells containing visible Hsp104-RFP puncta is quantified for each strain. Data 
shown are the means of three independent biological repeat experiments ±SD. Significance is shown compared 
with the wild-type strain; ***p < 0.001. (C) Western blot analysis of Hsp104 protein levels. Blots were probed 














































































3SCientiFiC RepoRts |  (2018) 8:3894  | DOI:10.1038/s41598-018-22183-2
ski8, dom34, and hbs1 mutant strains, whilst a higher increase was observed in NMD (upf1, upf2) mutants with 
approximately 16–18% of cells examined contained visible Hsp104 puncta (Fig. 1B). Western blot analysis was 
used to confirm that these differences did not arise due to any differences in Hsp104 expression levels which were 
similar in the wild-type and mRNA surveillance mutant strains (Fig. 1C and Supplementary Fig. 1).
Protein aggregates were purified and visualised using an established biochemical approach that separates 
insoluble proteins from soluble proteins by differential centrifugation, and removes any contaminating mem-
brane proteins using detergent washes10,24,25. Aggregates were prepared from the wild-type and mRNA sur-
veillance mutants, separated using SDS-PAGE and visualized by silver-staining (Fig. 2A). Low levels of protein 
aggregation were observed in the wild-type strain and increased aggregation was observed in all mRNA surveil-
lance pathway mutants.
Identification of aggregated proteins in mRNA surveillance mutants. The proteins that aggregate 
following loss of mRNA surveillance pathways were identified using mass spectrometry. We focused on single 
NMD (upf2) and NGD (hbs1) mutants along with ski7 and ski8 mutants. Our analysis identified 246 (wild-type), 
428 (ski7), 399 (ski8), 429 (upf2) and 428 (hbs1) aggregated proteins. More aggregated proteins were identified 
in the mRNA surveillance mutants compared with the wild-type strain but there was generally a large overlap 
in the proteins that aggregated in both the wild-type and mutant strains (Fig. 2B). In pair-wise comparisons 
more proteins were found to be uniquely aggregated in mRNA surveillance mutants (ski7 = 45%; ski8 = 42%; 
upf2 = 41%; hbs1 = 45%) compared with the wild-type strain (wild-type = 3–5%). There was also a large overlap 
(198 proteins) in the proteins that aggregated in all five strains, indicating that most proteins aggregate because 
they are aggregation-prone rather than arising due to any mutant specific-effects (Fig. 2C). Some unique proteins 
were identified (ski7 = 42; ski8 = 36; upf2 = 42; hbs1 = 11) suggesting that a few proteins do aggregate in an mRNA 
surveillance pathway-specific manner.
Figure 2. Identification of aggregated proteins in mRNA surveillance mutant strains. (A) Protein aggregates 
were isolated from the wild-type and mRNA surveillance mutant strains and analysed by SDS-PAGE and 
silver staining. (B) Proteins within insoluble aggregate fractions were identified by LC-MS and Venn diagrams 
show pairwise comparisons of the aggregated proteins in the wild-type and mutant strains. (C) Venn diagram 
comparing the aggregated proteins in the wild-type and mRNA surveillance mutant strains. 198 proteins were 
identified that aggregate in all five strains and are referred to as the Common-set.
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Functional analysis of aggregated proteins in mRNA surveillance mutants. Given that protein 
function is generally related to its subcellular localisation, we next examined the localisation of the aggregated 
proteins in the wild-type and mRNA surveillance mutant strains. For comparison, we used a list of yeast proteins 
detected by mass spectrometry in logarithmically growing cells, referred to as the MS-set, to represent the prop-
erties of unaggregated proteins26. No major differences were observed in the proportion of aggregated proteins 
localised to different compartments in the wild-type and mutant strains. The major fraction of proteins examined 
were predicted to localise in the cytoplasm of all strains examined (Fig. 3A). Proteins were also predicted to local-
ise to the nucleus, mitochondrion, ER, Golgi, vacuole, cytoskeleton and transport vesicles.
We next analysed the datasets for enrichment of any functional categories to determine whether particu-
lar biological processes may be affected by protein aggregation following loss of mRNA surveillance pathways. 
Significant functional enrichment within the datasets was determined using the MIPS Functional Catalogue27. 
Proteins present in the aggregates isolated from the wild-type (246), ski7 (428), ski8 (399), upf2 (429) and hbs1 
(349) mutant strains were compared. Our analysis revealed that the proteins within the aggregates isolated from 
all strains could generally be grouped into two major overarching categories: protein synthesis and proteins with 
binding function or cofactor requirement (Fig. 3B). For mRNA surveillance mutants, proteins in two additional 
major categories were enriched: metabolism and energy. Additionally, stress categories including the heat shock 
response and the unfolded protein response were enriched in the mRNA surveillance mutants but not in the 
wild-type.
Figure 3. Localisation and functional analysis of aggregated proteins in mRNA surveillance mutants. (A) 
Histogram showing the relative localisation of the proteins present in the aggregates isolated from the wild-
type (246), ski7 (428), ski8 (399), upf2 (429) and hbs1 (349) mutant strains. The localisation of proteins in the 
MS-set and the common set are also presented for comparison. Proteins with annotated localisation for each 
cellular component were compared to the total proteins with annotated localisation in each data set. (B) MIPS 
functional categorisation of aggregated proteins identified in the wild-type and mRNA surveillance mutant 
strains. Significantly enriched functional categories within the data-sets were determined using FunCat. Results 
are ordered on MIPS category classification numbers and overarching categories are in capitals. Confidence of 
each classification category is shown as Bonferroni corrected p-values.
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Analysis of the physicochemical properties of aggregated proteins identified in mRNA sur-
veillance mutants. We next assessed the physicochemical properties of the aggregated proteins within our 
datasets to determine whether they possess particular properties which make them aggregation-prone. For this 
analysis, we compared the Common-set consisting of 198 proteins which aggregate in all strains including the 
wild-type (Fig. 2C, middle panel), with the proteins which were found to specifically aggregate in mRNA sur-
veillance mutant strains but not in the wild-type strain (Fig. 2B: ski7, n = 199; ski8, n = 173; upf2, n = 198; hbs1, 
n = 133).
Analysis of the aggregated proteins in the Common-set revealed that they are significantly more abundant (as 
indicated by the number of molecules/cell), more highly expressed (as indicated by a higher codon adaptation 
index; CAI) and are translated at a higher rate (as determined using translational efficiency measurements28) 
compared with the MS-set (Fig. 4A–C). We used a global proteome turnover database29 to compare the stability 
of the proteins in their native folded states and found that the proteins in the Common-set also show an average 
longer half-life compared with the proteins in the MS-set (Fig. 4D). Similarly, more highly expressed, abun-
dant and stable proteins were also identified in the aggregate fractions isolated from mRNA surveillance mutant 
strains, compared with the MS-set (Fig. 4A–D). However, the proteins which aggregated in mRNA surveillance 
mutants were generally less abundant, less highly expressed and less stable that the proteins in the Common-set 
suggesting that the threshold for aggregation may be reduced in mRNA surveillance mutants.
To further examine the aggregated proteins identified in mRNA surveillance mutants, we compared a number 
of physicochemical properties. Proteins within the Common-set and mRNA surveillance mutant sets were signif-
icantly enriched for hydrophobic proteins in agreement with hydrophobicity being a driver of protein aggregation 
(Fig. 5A). There was no enrichment for proteins with altered pI’s in the Common, upf2 and hbs1 sets, whereas, 
Figure 4. Proteins within aggregate fractions are abundant and highly expressed. Comparison of the aggregated 
proteins present in the Common-set (198 proteins) with proteins present in mRNA surveillance mutant only 
sets (ski7, n = 199; ski8, n = 173; upf2, n = 198; hbs1, n = 133). Aggregated proteins were compared with a list 
of unaggregated proteins identified by mass-spectrometry referred to as the MS-set (Washburn et al. 2001). 
(A) The abundance of proteins (molecules/cell) in each set during non-stress conditions47. (B) The codon 
adaptation index (CAI) as an indicator of gene expression level. (C) Tranlsational Efficiency (TE) expressed as 
the ratio of ribosome footprint density to mRNA density28. (D) Comparison with protein stability measured as 
protein half-lives in hours29. Mann–Whiney U-tests were used to assess the statistical significance of observed 
differences: *p < 0.05, **p < 0.01, ***p < 0.001.
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the aggregated proteins identified in the ski7 and ski8 sets tended to have lower pI’s. No differences in the sizes 
(molecular weight) of the aggregated proteins were observed (Fig. 5C).
For comparison, we also examined the physicochemical properties of the uniquely aggregated proteins iden-
tified in each of the mRNA surveillance mutants (Fig. 2C: ski7 = 42; ski8 = 36; upf2 = 42; hbs1 = 11) to determine 
whether they possess any particular properties which might cause their aggregation to be mutant-specific. No 
significant enrichments for any functional categories or subcellular localizations were identified in these data-
sets. It should be noted that this may not be surprising given the relatively small sizes of these datasets. However, 
unlike the aggregated protein datasets used above (proteins which aggregate in mRNA surveillance mutant 
strains but not in the wild-type strain using pair-wise comparisons) there was no enrichment for highly expressed 
(translational efficiency, CAI), abundant (molecules per cell) or stable (T1/2) proteins compared with the MS-set 
(Supplementary Fig. 2A–D). There was also no enrichment for hydrophobic proteins apart from in the hbs1 
mutant, although it should be noted that this dataset only contains 11 proteins (Supplementary Fig. 2E). These 
data further emphasise the idea that the threshold for proteins to aggregate is reduced in mRNA surveillance 
compared with a wild-type strain.
The proteins which aggregate in mRNA surveillance pathways are similar to the proteins that 
aggregate during nascent protein misfolding and ageing. We compared the proteins that aggregate 
in mRNA surveillance mutants with proteins that aggregate during ageing. Yeast cells have been used as a model 
for the chronological lifespan of post-mitotic cells and 480 proteins have been identified which aggregate during 
yeast ageing30. We found that there was a significant overlap between the proteins which aggregate during ageing 
and the Common-set, and also in the proteins that aggregate in the mRNA surveillance pathways suggesting that 
errors in translation may account for some of the aggregation that occurs during ageing (Fig. 6).
We also compared the proteins that aggregate in mRNA surveillance mutants with proteins that have been 
shown to aggregate in response to different stress conditions. Nascent protein misfolding can be caused by the 
proline analogue azetidine-2-carboxylic acid (AZC) which is competitively incorporated into nascent proteins 
in place of proline. AZC alters the conformation of the polypeptide backbone resulting in decreased thermal 
stability and misfolding31. Significant overlaps were identified between AZC-induced aggregates10 and the 
Figure 5. Analysis of physicochemical properties of aggregated proteins. (A) Comparison of the grand average 
of hydrophobicity (GRAVY) scores as a measure of hydrophobicity. (B) Comparison of Isoelectric points (pI). 
(C) Comparison of protein size (kDa). Mann–Whiney U-tests were used to assess the statistical significance of 
observed differences: *p < 0.05, ***p < 0.005. (D) Comparison with proteins that are co-translational substrates 
of Ssb232.
www.nature.com/scientificreports/
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aggregated proteins in the Common-set and mRNA surveillance pathway mutants suggesting that aggregation 
may occur during nascent protein misfolding in mRNA surveillance mutants (Fig. 6). We additionally examined 
whether aggregated proteins are enriched for co-translational substrates of Ssb chaperones using an available Ssb2 
data-set32. Ssb2, a member of the HSP70 family, is a ribosome-associated molecular chaperone that is involved 
in the folding of newly-synthesized polypeptide chains. In agreement with the idea that aggregated proteins are 
susceptible to aggregation during nascent protein folding, the Common-set was significantly enriched in proteins 
that are co-translational Ssb2 substrates compared to the MS proteome (Fig. 5D). In contrast to AZC stress, no 
significant overlaps were found between proteins that aggregate in response to oxidative stress conditions caused 
by hydrogen peroxide exposure10 and the proteins that aggregate in mRNA surveillance mutants (Fig. 6). There 
was however, a significant overlap between the Common-set and the hydrogen peroxide-set (Fig. 6). Similary, no 
significant overlaps were found between proteins which aggregate in response to acute heat stress conditions33 
and proteins which specifically aggregate in mRNA surveillance mutants (Fig. 6).
Finally we examined whether there is any correlation between mRNA levels and protein aggregation. We rea-
soned that if aggregation arises due to translation of mRNAs that are normally degraded in surveillance mutants, 
we might see an accumulation of these mRNAs in an mRNA surveillance mutant. For this analysis we compared 
the aggregated proteins with transcripts that have been identified as up-regulated in a upf2 mutant34. However, no 
correlation was found between the up-regulated mRNAs and the proteins which aggregate in mRNA surveillance 
mutants including the upf2 mutant (Fig. 6).
Discussion
mRNA quality control mechanisms recognise and degrade aberrant mRNAs including mRNAs containing pre-
mature stop codons (PTCs), mRNAs lacking termination codons and mRNAs containing structures which pro-
mote pausing during translation elongation19. We found that increased protein aggregation is a common property 
of mRNA surveillance mutants suggesting that a failure to degrade these mRNAs results in the production of 
aberrant proteins. This is similar to recent findings which have shown that disrupting the ribosome-associated 
quality control (RQC) complex, which recognises stalled proteins and promotes their ubiquitination and degra-
dation, similarly results in protein aggregation35,36.
Our analysis was performed using cells grown under non-stress conditions indicating that mRNA surveillance 
pathways normally act to prevent aberrant mRNAs driving translation-dependent aggregation during normal 
growth and metabolism. There are a number of possible mechanisms by which loss of surveillance pathways 
might promote aggregation. For example, aberrant or truncated proteins may be produced by translation of 
mRNAs which would normally be degraded in surveillance mutants. We did not see any accumulation of mRNAs 
encoding aggregated proteins in a upf2 mutant. However, this may simply indicate that any mRNAs that accumu-
late, may do so at relatively low levels. Alternatively, an accumulation of stalled/aberrant polypeptides in mRNA 
surveillance mutants could sequester chaperones leading to the aggregation of other proteins. These proteins may 
aggregate themselves as well as act to nucleate the aggregation of other proteins.
Our analysis identified a significant overlap in the proteins that aggregate in different mRNA surveillance 
pathway mutants. Not surprisingly therefore, the intracellular localisation of the proteins that aggregate in mRNA 
surveillance mutants is similar to the localisation of the proteins that aggregate in a wild-type strain. Similarly, 
the protein functional categories that might be affected as a result of protein aggregation titrating proteins away 
from their normal soluble forms is predominantly the same in wild-type and mRNA surveillance mutant strains. 
This is consistent with the idea that the increased protein aggregation detected in mRNA surveillance pathway 
mutants predominantly arises due to the increased aggregation of a core set of what are already aggregation-prone 
proteins, rather than aggregation occurring in a mutant-specific manner.
Many studies have identified hydrophobicity as a driving force for protein aggregation. The burial of hydro-
phobic segments within protein structures prevents exposed hydrophobic regions from interacting with other 
exposed hydrophobic regions leading to aberrant protein-protein interactions37–39. In agreement with this idea, 
the aggregated proteins identified in mRNA surveillance mutants were commonly enriched for hydrophobicity. 
Aggregation-prone proteins also tend to be more abundant and highly expressed, compared with unaggregated 
proteins10–12. Similarly, the aggregated proteins identified in mRNA surveillance mutants were enriched for highly 
Figure 6. The proteins which aggregate in mRNA surveillance pathways are similar to the proteins which 
aggregate during nascent protein misfolding and ageing. Comparison of the aggregated proteins present in 
the Common-set and mRNA surveillance mutant sets with other datasets including proteins that aggregate 
during postmitotic ageing in yeast30, proteins that aggregate during AZC stress10, proteins that aggregate during 
hydrogen peroxide stress10, proteins that aggregate during heat-shock33 and mRNAs that are increased greater 
than two-fold in a upf2 mutant compared with a wild-type strain34. Numbers in brackets indicate the size 
of each dataset. The significance of overlaps was determined by a hypergeometric test. Blue: p < 0.05, green: 
p < 0.01, red: p < 0.001.
www.nature.com/scientificreports/
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translated and abundant proteins. The threat of aggregation may be unavoidable in highly concentrated proteins 
as they pose a bigger challenge for the proteostasis network, particularly when the proteostasis machinery is 
compromised. Estimates have suggested that the aggregation tendency of globular proteins may be as high as 20% 
in diverse proteomes40. This may result from the crowded and complex environment that highly expressed nas-
cent proteins encounter resulting in a greater chance of specific and non-specific molecular interactions, making 
aggregation more likely to occur41.
There was a significant overlap in the proteins that aggregate in mRNA surveillance mutants compared with 
the proteins that aggregate in response to nascent protein misfolding, suggesting that protein aggregation in 
mRNA surveillance mutants may primarily occur during protein synthesis and folding. The commonly aggre-
gated proteins were also enriched for co-translational Ssb2 substrates further emphasising that protein misfolding 
may occur co-translationally. Taken together, our data are consistent with the idea that mRNA surveillance path-
ways normally act to suppress the production of abnormal proteins resulting from aberrant translation events.
The fact that there was a significant overlap with the proteins that aggregate in ageing yeast cells suggests that 
translation-dependent aggregation may be a particular problem as cells age42. Two types of mRNA transcripts 
may be targets for surveillance pathways: those where genetic features make them a constitutive surveillance 
target (e.g. because of long 3′ UTRs or PTCs) and those where random damage produces aberrant features that 
are recognised by surveillance pathways. The balance between these two types of target may shift during ageing 
where higher levels of random damage may be expected to influence the fidelity of translation42,43. There was a 
strong correlation with the proteins that aggregate in response to nascent protein misfolding, whereas, there was 
little correlation with the proteins that aggregate following a denaturing stress caused by elevated temperature, 
further emphasising that aberrant translational events most likely underlie the high levels of aggregation observed 
in mRNA surveillance mutants. An increased understanding of the roles of mRNA surveillance pathways in pro-
tecting against the formation of non-functional RNAs and the subsequent production of abnormal proteins will 
be important given the established links between the degradation of aberrant mRNAs and human diseases44–46.
Methods
Strains and growth conditions. Yeast strains used were isogenic derivatives of the wild-type 74D-694 
(MATa ade1–14 ura3–52 leu2–3,112 trp1–289 his3–200) including ski7::HIS3, ski8::HIS3, upf1::HIS3, upf2::HIS3, 
dom34::HIS3 and hbs1::HIS3. Strains were grown at 30 °C (180 rpm) in SCD medium [2% w/v glucose, 0.17% 
w/v yeast nitrogen base (Appleton Wood) supplemented with Synthetic Complete (SC) Kaiser amino acid mixes 
(Formedium, England)].
Analysis of insoluble protein aggregates. All strains were harvested at the same cell optical density 
(exponential phase) and Insoluble protein aggregates isolated exactly as previously described25. Briefly, 20 ODs of 
cells were harvested by centrifugation at 4000 rpm, 4 °C for 10 min. Cells were washed in 1 ml of Aggregate lysis 
buffer (ALB – 50 mM potassium phosphate, 1 mM EDTA, 5% (v/v) glycerol, 1 mM PMSF and 1 × complete mini 
protease cocktail (Roche). Cells were resuspended in 300 μl ALB and spheroplasts were generated following treat-
ment with lyticase (1 mg/ml) for 30 min at 30 °C. Cell breakage was achieved by sonication (Sonifier 150, Branson; 
8 × 5 s, Level 4) and samples were adjusted to equal protein concentrations before isolation of protein aggregates 
by centrifugation at 13000 rpm, 4 °C for 20 min. Insoluble fractions were resuspended in a buffer containing ALB 
buffer with 2% (v/v) Igepal CA-630 (Sigma) through sonication (4 × 5 s, Level 4). Samples were centrifuged at 
13000 rpm for 20 min at 4 °C and the detergent wash was repeated. Residual detergent was removed by two washes 
with ALB and the pellet was resuspended by sonication. The final insoluble fraction was resuspended in 80 μl 
ALB and 20 μl reducing 4 × protein loading buffer, separated by reducing SDS-PAGE (10% gels) and visualised by 
silver staining using the Bio-Rad silver stain plus kit.
Aggregated proteins were identified by mass spectrometry (performed by the Biomolecular Analysis Core 
Facility, Faculty of Biology, Medicine and Health, The University of Manchester) in triplicate for each condi-
tion. For protein identification, protein samples were run a short distance into SDS-PAGE gels and stained using 
Instant Blue protein stain (Expedeon). Total proteins were excised, trypsin digested, and identified using liquid 
chromatography-mass spectrometry (LC-MS). Proteins were identified using the Mascot mass fingerprinting 
programme (www.matrixscience.com) to search the NCBInr and Swissprot databases. These results were put into 
Scaffold software, (https://www.proteomesoftware.com/products/free-viewer/) that conducts a statistical valida-
tion of the data, at both the peptide and protein levels. We selected proteins that had at least 95% statistical con-
fidence of being present in our samples. Final datasets for each condition were determined by selecting proteins 
that were identified in at least two of the three replicates.
Protein and western blot analysis. Protein extracts were electrophoresed under reducing conditions on 
SDS-PAGE minigels and electroblotted onto PVDF membrane (Amersham Pharmacia Biotech). Bound antibody 
was visualized using LI-COR Odyssey-FC. Primary antibodies used were Pgk1 (459250, ThermoFisher Scientific) 
and Hsp104 (ab2924, Abcam).
Fluorescence microscopy. The plasmid containing fluorescently tagged Hsp104 has been described pre-
viously21. Cells expressing Hsp104-RFP were washed and immobilised on 10% poly-L-lysine-coated slides. All 
images were acquired on a Delta Vision (Applied Precision) restoration microscope using a 100 × /NA 1.42 Plan 
Apo objective and TRITC filter (excitation BP555/28 nm, emission BP617/63) from the Sedat filter set (Chroma). 
Raw images were then deconvolved using the Softworx software and maximum intensity projections of these 
deconvolved images are shown in the results. At least 100 cells were visualized in triplicate experiments for each 
strain and the percentage of cells containing visible puncta scored.
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Statistical analyses. Datasets for each condition were assessed for functional enrichment (p-value > 0.01; 
Bonferroni corrected) of functional categories (MIPS database) using FunCat (available at http://www.
helmholtz-muenchen.de/en/ibis). Protein abundance data was retrieved from the PaxDB integrated dataset 
(available at http://pax-db.org). The proteins that aggregate in aged-yeast, AZC, hydrogen peroxide and heat 
stressed yeast have been described previously10,30,33 and statistical significance of the overlap was evaluated with a 
hypergeometric test. Venn diagrams and visualization of the distribution of protein hits between conditions were 
made using Bio Venn (http://www.biovenn.nl). Physicochemical data, translation rates and chaperone interac-
tions were evaluated with pair wise Mann-Whitney-Wilcoxon U-tests using GraphPad Prism.
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